Ono Pharmaceutical Co. Ltd

This study is testing whether a new drug called ONO-1110 can help reduce symptoms of major depression. It will involve about 100 Japanese adults with moderate to severe depression. Participants will be randomly assigned to receive either the new drug or a placebo for 8 weeks to s…

This study is testing a new oral medication called ONO-2020 to see if it is safe and can help improve memory and thinking in people with mild to moderate Alzheimer's disease. About 240 participants will take either the drug or a placebo (a dummy pill) daily for 26 weeks. The main…

This study is testing whether adding an experimental drug called ONO-4578 to standard chemotherapy and immunotherapy works better for advanced stomach cancer. It will involve about 226 patients who have not yet received chemotherapy for their cancer. The main goal is to see if th…

This study is testing an investigational drug called tirabrutinib for a rare and aggressive cancer called primary central nervous system lymphoma (PCNSL), which starts in the brain or spinal cord. It has two parts: one for patients whose cancer has returned or resisted prior trea…

This study is testing an investigational drug called ONO-1110 to see if it can safely reduce pain in Japanese adults suffering from postherpetic neuralgia, a type of long-lasting nerve pain that can follow a shingles outbreak. About 140 participants will be randomly assigned to r…

This study is testing an investigational drug called ONO-1110 to see if it can safely reduce pain and improve other symptoms in people with fibromyalgia. It will involve about 160 Japanese adults who have been diagnosed with fibromyalgia. Participants will be randomly assigned to…

This study is testing an investigational drug called ONO-1110 to see if it can safely reduce the fear and avoidance that people with social anxiety disorder experience. It will involve about 100 Japanese adults with moderate-to-severe social anxiety. Participants will be randomly…